Storia della carriera di David Green
Precedenti posizioni note di David Green
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| AMGEN INC. | Direttore Tecnico/Scientifico/R&S | 01/09/1997 | 01/02/2008 |
| ABBOTT LABORATORIES | Corporate Officer/Principal | - | - |
| UNITED THERAPEUTICS CORPORATION | Direttore/Membro del Consiglio | - | - |
| ReSearch Pharmaceutical Services, Inc. | Direttore Tecnico/Scientifico/R&S | - | - |
Aquinox Pharmaceuticals, Inc.
 Aquinox Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aquinox Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company. It discovers and develops targeted therapeutics for inflammation and immuno-oncology. It also focuses on anti-inflammatory product candidates targeting SHIP1, which is a key regulator of an important cellular signaling pathway in immune cells, known as the PI3K pathway. The company was founded by Raymond J. Andersen, David J. Main, Low Fung Mui, Christopher John Ong, and Gerald Krystal on December 26, 2003 and is headquartered in Vancouver, Canada. | Direttore Tecnico/Scientifico/R&S | - | - |
Statistiche
Distribuzione geografica
| Stati Uniti | 5 |
| Canada | 2 |
Posizioni
| Chief Tech/Sci/R&D Officer | 3 |
| Director/Board Member | 1 |
| Corporate Officer/Principal | 1 |
Settori
| Health Technology | 5 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 3 |
|---|---|
| UNITED THERAPEUTICS CORPORATION | Health Technology |
| AMGEN INC. | Health Technology |
| ABBOTT LABORATORIES | Health Technology |
| Aziende private | 2 |
|---|---|
Aquinox Pharmaceuticals, Inc.
Aquinox Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aquinox Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company. It discovers and develops targeted therapeutics for inflammation and immuno-oncology. It also focuses on anti-inflammatory product candidates targeting SHIP1, which is a key regulator of an important cellular signaling pathway in immune cells, known as the PI3K pathway. The company was founded by Raymond J. Andersen, David J. Main, Low Fung Mui, Christopher John Ong, and Gerald Krystal on December 26, 2003 and is headquartered in Vancouver, Canada. | Health Technology |
| ReSearch Pharmaceutical Services, Inc. |
- Borsa valori
- Insiders
- David Green
- Esperienza
